All experiments started at 08.00 h, the subjects having fasted and abstained from tobacco and alcohol overnight.
cyclic AMP (cAMP) in plasma in man may be manyfold, the increase in plasma cAMP upon beta-ad¬ renergic stimulation (e.g. by adrenaline) is probab¬ ly due to leakage of cAMP into the blood following activation of the beta-receptor (1, 2) . Thus, incre¬ ments in plasma cAMP after beta-agonist stimula¬ tion may reflect integrated second messenger func¬ tion of the tissues activated by the agonist. In ex¬ perimental situations where changes in beta-adre¬ nergic sensitivity are likely to exist, an altered relationship between plasma concentrations of be¬ ta-adrenoceptor agonist and plasma cAMP might therefore support the existence of such differ¬ ences. This in vivo method for the determination of beta-adrenergic sensitivity is based on the assump¬ tion that beta-adrenoceptor blockade during con¬ comitant beta-agonist stimulation prevents the in¬ crease in plasma cAMP. However, such data are not available.
The aim of the present study was therefore to study the relationship between plasma concentra¬ tions of catecholamines and cAMP during graded infusions of adrenaline and to compare these with changes in physiological variables induced by the infusion. Finally, the effect of beta-adrenergic blockade during these experimental conditions was assessed.
Subjects and Methods

Study population
Eight healthy male subjects, mean age 34 years (range 27-42) volunteered for the study after giving informed consent. The subjects took no drugs. The experiments were approved by the local Ethical Committee.
Experimental protocol
All experiments started at 08.00 h, the subjects having fasted and abstained from tobacco and alcohol overnight.
The subjects were studied two times in randomized 5 ml RIA buffer and the cAMP eluted with 2 ml of methanol. Finally, the methanol was evaporated under nitrogen at 50°C and the residue dis¬ solved in 1 ml RIA buffer. Of this solution 100 ul was removed for liquid scintillation counting and recovery estimation, and various aliquots (25, 50 and 100 ul) were subjected to radioimmunoassay. Tracer for radioimmunoassay. Succinyl-cAMP tyrosine methylester, Sc-AMP-TME (Sigma M 2257) was used for iodination by a iodogen procedure.
A plastic tube was coated with iodogen (1, 3, 4, 6 tetrachloro-3ct, 6ct-diphenyl Glycoluril, Pierce, UK) using 150 ul of a solution containing 1 mg iodogen/25 ml dichloromethan evaporated to dryness; 15 ul of Sc-AMP-TME (1 g/1 water), 80 ul 0.5 mol/1 sodium phosphate buffer, pH 7.4, and 100 nl Na125I (600 nCi) were transferred to the io¬ dogen tube. The solution was vortexed and the iodination allowed to proceed for 2 min at room temperature. The total reaction mixture was loaded onto a Sephadex G25 column (1 x 75 cm) with 1000 ul of water. Gel filtration was carried out using 0.1 mol/1 phosphate buffer, pH 7.4, as eluant and fractions of 3 ml were collected. Only one radioactive peak appeared, with a peak at 123 ml. (3) . In¬ sulin was measured by radioimmunoassay (4) . Pancreatic glucagon (using antibody 4305) and gut glucagon (using antibody 4304) were measured with previously described radioimmunoassays (4 
Results
Plasma adrenaline increased with increasing adren¬ aline infusion rate in both experiments (adrenaline infusion and adrenaline plus propranolol infusion) (Fig. 1) . The increase in plasma adrenaline was sig¬ nificantly greater (p<0.05) in the propranolol in¬ fusion experiment than during adrenaline infu¬ sion. Plasma noradrenaline increased insignifi¬ cantly during adrenaline infusion, whereas plasma noradrenaline decreased significantly (p<0.025) during combined adrenaline and propranolol in¬ fusion (Fig. 1) .
Plasma cAMP increased significantly during adrenaline infusion (Fig. 1) ; during combined adrenaline and propranolol infusion there was a small but significant increase in plasma cAMP at the end of the experiment (Fig. 1) . A significant correlation (p<0.025) was found between incre¬ ments in plasma adrenaline and plasma cAMP during adrenaline infusion (Fig. 2) ; no significant correlation was found during adrenaline and pro¬ pranolol infusion. during adrenaline infusion ( Fig. 1 (Fig. 1) . Blood glucose increased significantly in both infusion ex¬ periments (Fig. 3) ; at the end of the experiments, the increase in blood glucose was significantly greater in the adrenaline infusion experiments than with the combined adrenaline and proprano¬ lol infusion (p<0.05).
Similarly, lactate, glycerol and betahydroxy buty¬ ric acid concentrations increased significantly at adrenaline infusion rates 2.5 ng/min and 5 ng/min (Fig. 3) ; smaller but still significant increments were found at 5 ng/min in the combined infusions (p<0.05).
Heart rate increased significantly at 2.5 ng/min and at 5 ng/min during adrenaline infusion (Fig. 4) ; a significant decrease was found in heart rate at 5 ng/min in the combined infusion experiment (Fig.   4 ).
Systolic blood pressure increased and diastolic blood pressure decreased during adrenaline infu¬ sion; mean blood pressure (calculated as diastolic pressure + 'A (systolic -diastolic pressure)) did not change significantly during these experimental conditions. During combined adrenaline and pro¬ pranolol infusion there was a significant increase in both systolic and diastolic blood pressure, and mean blood pressure increased significantly (p<0.025) (Fig. 4) .
Plasma cAMP decreased slightly (from 20 to 19 nmol/1) after noradrenaline infusion at 5 ng/min for 1 h; plasma noradrenaline increased from 1.61 to 4.79 nmol/1 in these experiments.
Discussion
The main finding of the present study is a linear relationship between increments in plasma adren¬ aline and plasma cAMP concentrations during graded adrenaline infusions in healthy subjects. The increase in plasma cAMP was abolished by concomitant infusion of a beta-adrenoceptor block¬ ing agent at low adrenaline infusion rates (0.5 and 2.5 ng/min), whereas a small but significant incre¬ ment was found at an adrenaline infusion rate of 5 ng/min, probably owing to incomplete beta-adre¬ noceptor blockade. Thus, measurements of plasma cAMP during beta-agonist stimulation may be em¬ ployed in the assessment of whole-body beta-ad¬ renoceptor responsiveness in man.
In vitro stimulation of intact cells (e.g. lympho¬ cytes) with adrenaline results in increased cAMP production which is blocked by addition of propranolol to the medium (7, 8 (14) , as confirmed by lack of increase in plasma cAMP during iv noradrenaline infusion in the high physiological range in the present study.
The blood pressure response to-adrenaline was
